Grants for For profit organizations other than small businesses - Science and Technology

The DOD Pancreatic Cancer, Focused Pilot Award is a grant that supports innovative research projects aimed at improving the quality of life for pancreatic cancer patients, with a focus on areas such as healthcare access, mental health, psycho-social issues, nutrition, education, and symptom management.

The "ROSES 2024: A.41 SERVIR Applied Sciences Team" grant is a funding opportunity supported by NASA and USAID, aiming to enhance the use of Earth observations to address environmental and developmental challenges in Africa, Asia, and Latin America by co-developing practical applications of satellite data to support decision-making in areas like agriculture, water security, and climate resilience.

This challenge invites engineers and materials innovators worldwide to create a cost-effective, corrosion-resistant lining for flow meters used in harsh industrial environments, with the potential for significant monetary awards and collaboration opportunities with a leading automation company.

This funding opportunity invites a wide range of organizations, including academic institutions and businesses, to propose innovative research and technology projects that enhance naval aviation capabilities for the U.S. Navy.

This grant provides funding for innovative research projects aimed at improving the understanding and treatment of eye injuries and visual dysfunction related to military service.

This funding opportunity supports community-based healthcare organizations in implementing educational initiatives and system-level changes to improve care for patients with relapsed or refractory multiple myeloma, particularly through the use of bispecific antibody therapies.

The Massachusetts Clean Energy Technology Center (MassCEC) is offering Climate-Critical Workforce Training, Equipment, and Infrastructure Grants (“Climate Training Grants”) to increase access to modern, relevant training equipment and infrastructure. These grants provide direct funding and technical assistance to organizations that can build and scale career pathways and upskilling programs. The core mission alignment is to help Massachusetts residents access and advance in climate-critical priority occupations, thereby addressing clean energy and climate tech employer needs and providing high-quality training and support opportunities across the Commonwealth. The target beneficiaries for these grants are Massachusetts residents who can benefit from career pathways and upskilling programs in climate-critical priority occupations. The impact goals are to fill workforce gaps in climate-critical sectors, expand recruitment pipelines, and create new or expand existing technical and job readiness training opportunities. This initiative also aims to create and expand career advancement programming and upskilling training for incumbent workers, ensuring businesses can grow to support the state’s climate goals. The program prioritizes several key areas, including expanding recruitment pipelines to broaden access to climate-critical priority occupations, creating and expanding technical and job readiness training, and fostering career advancement and upskilling opportunities. It also focuses on leveraging effective workforce development models like registered apprenticeships and pre-apprenticeships, developing new relationships with employers for job placements, and establishing wraparound and retention support services to address barriers to entry and advancement. Furthermore, a significant focus is on expanding the availability and effectiveness of climate-critical training by securing modern equipment and infrastructure resources. Expected outcomes include a more robust workforce for climate-critical sectors, increased access for residents to high-quality training and job opportunities, and businesses expanding their capacity to meet climate goals. Measurable results will likely involve the number of residents trained, placed in climate-critical occupations, and upskilled, as well as the expansion of training programs, equipment, and infrastructure. The overall theory of change is that by investing in workforce development, equipment, and infrastructure, MassCEC can directly support the state's clean energy and climate tech employer needs while creating equitable access to career advancement for Massachusetts residents.

This grant provides funding for independent documentary films that explore the Asian American experience, intended for broadcast on public television.

This funding opportunity supports nonprofit organizations in New Jersey that are dedicated to improving the social, economic, and educational outcomes of Hispanic communities through various initiatives.

This grant provides funding to organizations that create and distribute accessible educational videos for children and youth with disabilities, ensuring they have equal access to high-quality learning materials.

This grant provides funding and support to early-stage U.S. startups developing innovative technologies that can meet critical needs of the Department of Defense.

This program provides funding for researchers and innovators to develop advanced technologies for rapidly identifying and sequencing complex protein-based biothreats, enhancing national security and defense capabilities.

This funding opportunity supports various organizations in recruiting and managing participants with kidney diseases for a national study aimed at improving understanding and treatment of these conditions.

This funding opportunity provides financial support for organizations and individuals to foster collaboration and innovation in sports technology between the United States and India, aiming to enhance engagement with U.S. sports analytics and medicine among Indian stakeholders.

This grant option, part of the Minnesota Spinal Cord Injury and Traumatic Brain Injury Research Grant Program, aims to support early-stage research into innovative treatments and rehabilitative techniques for spinal cord and traumatic brain injuries. The Tier 1 Pilot Project Grant does not require preliminary data but encourages it, reflecting early investment as researchers prepare to seek larger grants. The funding amount can reach up to $125,000 for a project duration of two years with an additional one-year no-cost extension.

The Era of Hope Scholar Award supports individuals early in their careers who have demonstrated significant potential to effect meaningful change in breast cancer. These individuals should be exceptionally talented scientists who have shown that they are the best and brightest in their field(s) through extraordinary creativity, vision, innovation, and productivity. They should have demonstrated experience in forming effective partnerships and collaborations and must exhibit strong potential for future leadership in breast cancer research.As the intent of the Era of Hope Scholar Award is to recognize creative and innovative individuals rather than projects, the central features of the award are the demonstrated ability of the individual named as the Principal Investigator (PI) in the application to go beyond conventional thinking in their field and the innovative contribution that the PI can make toward ending breast cancer. The application should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention.Experience in breast cancer research is not required; however, the application must focus on breast cancer, and the PI must commit a minimum of 25% level of time and effort during the period of performance to conduct breast cancer research under this award. Individuals from other disciplines who apply novel concepts to breast cancer are encouraged to submit.The PI is encouraged to assemble a research team that will provide the necessary expertise and collaborative efforts toward accomplishing the research goals. The PIs research team must include two or more breast cancer consumer advocates. As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer and are actively involved in a breast cancer advocacy organization. Their role should be independent of their employment, and they may not be employees of any organizations participating in the application. The consumer advocates should have a high level of knowledge of current breast cancer issues and the appropriate background and/or training in breast cancer research to contribute to the project. Their role should be focused on providing objective input throughout the research effort and its potential impact for individuals with, or at risk for, breast cancer.A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, the CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer-Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 BCRP priorities.Innovative research involving nuclear medicine and related techniques to support early diagnosis, more effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies.The CDMRP encourages research on health areas and conditions that affect women uniquely, disproportionately, or differently from men, including studies analyzing sex as a biological variable. Such research should relate anticipated project findings to improvements in women’s health outcomes and/or advancing knowledge for women’s health.The proposed research must be relevant to active-duty Service Members, Veterans, military beneficiaries, and/or the American public. Collaborations between researchers at military or Veteran institutions and non-military institutions are strongly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the partners bring to the research effort, ultimately advancing cancer research that is of significance to the Warfighter, military Families, and the American public.Clinical trials are allowed. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes:(1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.The funding instrument for awards made under the program announcement will be grants (31 USC 6304).The anticipated direct costs budgeted for the entire period of performance for an FY24 Era of Hope Scholar Award should not exceed $3.5M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $5.4M to fund approximately one Era of Hope Scholar Award application. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

This funding opportunity provides financial support to U.S.-based small businesses that have previously received Phase I awards to further develop and commercialize innovative research in agriculture, food systems, and environmental sustainability.

The DoD Traumatic Brain Injury and Psychological Health, Translational Research Award aims to fund research that accelerates the application of findings in psychological health and traumatic brain injury into clinical practice, leading to the development of healthcare products, technologies, or clinical practice guidelines that improve patient outcomes.

This grant provides funding for U.S.-based researchers and organizations to conduct innovative studies in microgravity that explore transport phenomena, with the goal of developing solutions that benefit life on Earth.

This grant provides funding for innovative research on brain and nervous system disorders, encouraging collaboration between U.S. and low- and middle-income country researchers to improve global health outcomes.